Work

475P A phase Ib study of NUC-3373, a targeted inhibitor of thymidylate synthase, in combination with standard therapies in patients with advanced colorectal cancer (NuTide:302)

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.996

Authors: J. Berlin, A.L. Coveler, K.K. Ciombor, F. Kazmi, J. Graham, M.L. Peters, J.W. Clark, M. Myers, A. De Gramont, T.R.J. Evans, S. Blagden

Institutions: Vanderbilt University, Vanderbilt University Medical Center, Fred Hutch Cancer Center, Churchill Hospital, Beatson West of Scotland Cancer Centre, Beth Israel Deaconess Medical Center, Harvard University, Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Nucana (United Kingdom), Institut Hospitalier Franco Britannique, Cancer Research UK Scotland Institute

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3203722465

FWCI: 0.082

Cites:

Cited by: 1

Related to: 10